Search results

Filter

Filetype

Your search for "*" yielded 546852 hits

Nerve cells could transform the treatment of Parkinson’s

At the end of October 2022, the Swedish Medical Products Agency gave the go-ahead for a clinical trial of the stem cell-based therapy STEM-PD for the treatment of Parkinson’s disease. The cells, generated from embryonic stem cells, have been in development for several years and will now be transplanted into patients with Parkinson’s to replace nerve cells lost due to the disease. The clinical tria

https://www.multipark.lu.se/article/nerve-cells-could-transform-treatment-parkinsons - 2025-10-07

Huntington’s metabolic dysfunctions – PhD interview with Elna Dickson

Huntington's disease is known as the "dance disease" due to the patient's characteristic motor symptoms. However, Elna Dickson's Ph.D. project shows that the disease also leads to pathological changes outside the brain. February 17, she defends her thesis about metabolic alterations in Huntington's disease. Now, she shares perspectives on her research journey. Tell us about your research! "Hunting

https://www.multipark.lu.se/article/huntingtons-metabolic-dysfunctions-phd-interview-elna-dickson - 2025-10-07

Does Alzheimer’s disease start inside neurons? – PhD interview with Tomas Roos

The aggregation of the protein Amyloid-beta (Abeta) into plaques outside the nerve cells has been recognized in patients with Alzheimer’s disease since 1905. But eliminating the plaques has not helped patients so far. Still, Tomas Roos thinks that Abeta matters, but we may need to focus on the aggregates elsewhere. On February 17, he defends his thesis about prion-like proteins in neurodegeneratio

https://www.multipark.lu.se/article/does-alzheimers-disease-start-inside-neurons-phd-interview-tomas-roos - 2025-10-07

First patient receives milestone stem cell-based transplant for Parkinson’s Disease

On 13th of February, a transplant of stem cell-derived nerve cells was administered to a person with Parkinson’s at Skåne University Hospital, Sweden. The product has been developed by Lund University and it is now being tested in patients for the first time. The transplantation product is generated from embryonic stem cells and functions to replace the dopamine nerve cells which are lost in the p

https://www.multipark.lu.se/article/first-patient-receives-milestone-stem-cell-based-transplant-parkinsons-disease - 2025-10-07

Electrodes grown in the brain

The boundaries between biology and technology are becoming blurred. Researchers at Linköping, Lund, and Gothenburg universities in Sweden have successfully grown electrodes in living tissue using the body’s molecules as triggers. The result, published in the journal Science, paves the way for the formation of fully integrated electronic circuits in living organisms. This news was initially publish

https://www.multipark.lu.se/article/electrodes-grown-brain - 2025-10-07

Genes and environment in PD – PhD interview with Kajsa Brolin

Kajsa Brolin explores how our genes and environment affect the risk of developing Parkinson’s disease. March 27, she defends her Ph.D. project partly based on MultiPark’s biobank sample collection. Here, she tells about the newly discovered genetic risk factor that might be specific to people in the southern part of Sweden. And is coffee really protective? Tell us about your research! “My research

https://www.multipark.lu.se/article/genes-and-environment-pd-phd-interview-kajsa-brolin - 2025-10-07

STEM-PD : A bench-to-bedside story by MultiPark researchers

After a decade of protocol development and preparations, MultiPark researchers have finally launched the clinical trial. Recently, dopamine-producing cells generated from embryonic stem cells were transplanted into the first Parkinson's patient at Skåne University Hospital. During the autumn 2022, the Swedish MPA (Läkemedelsverket) approved the clinical STEM-PD study. Several of MultiParks PIs hav

https://www.multipark.lu.se/article/stem-pd-bench-bedside-story-multipark-researchers-0 - 2025-10-07

Meet Our Scientists! – New podcast by young MultiPark researchers

Looking for the next step in your career? In need of some scientific inspiration? Or are you just curious about what MultiPark´s senior researchers are doing and their professional journey? Listen to MultiPark’s new podcast series “Meet our scientists”! In a newly launched podcast, young MultiPark researchers interview our research group leaders about their academic journey and main scientific foc

https://www.multipark.lu.se/article/meet-our-scientists-new-podcast-young-multipark-researchers - 2025-10-07

WORLD PARKINSON's DAY: Transplantations for Parkinson's disease – A time travel

In the early 1950s, no one knew what caused Parkinson's disease. Then, Arvid Carlsson's discovery of dopamine opened the door to world-leading transplantations for Parkinson's patients. Thanks to the pioneering basic research at MultiPark, stemcell-derived neural cells can now be tested in a clinical trial for the first time. In Parkinson's disease, the nerve cells in an area of the brain that con

https://www.multipark.lu.se/article/world-parkinsons-day-transplantations-parkinsons-disease-time-travel - 2025-10-07

Genetics of Neurodegenerative Diseases – A special interest group

Genetics are one of the keys to understanding neurodegenerative disease. That is why MultiPark researchers with expertise in genetics gather across research groups. Genetics of neurodegenerative diseases is a new special interest group (SIG) addressing scientific and technological needs to unravel the genetics behind diseases such as Parkinson’s and Alzheimer’s. Andreas Puschmann tells about how h

https://www.multipark.lu.se/article/genetics-neurodegenerative-diseases-special-interest-group - 2025-10-07

Double success for MultiPark research groups in prestigious EU grant round

Three researchers at Lund University, all with a long list of significant research credentials, have been awarded the ERC Advanced Grant worth EUR 2.5 million each to further develop and advance their research projects. Two of them are MultiPark research leaders. They do research on chaperone proteins’ function in neurodegenerative diseases and blood tests for rapid screening of drugs in the treat

https://www.multipark.lu.se/article/double-success-multipark-research-groups-prestigious-eu-grant-round - 2025-10-07

Superstars coming to Lund for pharmaceutical symposium sponsored by MultiPark

Several Nobel laureates, renowned scientists, and successful biotech entrepreneurs are coming to Lund in May to participate in the Lund Spring Symposium, an international pharmaceutical symposium sponsored by MultiPark. Sarah Tabrizi, a high profile Huntington researcher, and some of MultiPark's own researchers will speak. Medications are the physician's primary tool when treating their patients,

https://www.multipark.lu.se/article/superstars-coming-lund-pharmaceutical-symposium-sponsored-multipark - 2025-10-07

Smart Built Environment nytt svenskt strategiskt innovationsområde

Smart Built Environment är ett av de fem forsknings- och innovationssatsningar som får dela på sammanlagt 430 miljoner kronor från stat och näringsliv. VINNOVA, Energimyndigheten och Formas har beslutat att göra Smart Built Environment till ett av fem strategiska innovationsområden i Sverige. Staten och näringslivet satsar gemensamt inledningsvis upp till 200 miljoner kronor i programmet, under en

https://www.nateko.lu.se/sv/artikel/smart-built-environment-nytt-svenskt-strategiskt-innovationsomrade - 2025-10-07

Lunds universitet rankad som nr 20 i världen inom geografi

QS Top University ranking för 2015 placerar Lunds universitet som världens tjugonde inom ämnet geografi. QS World University Ranking placerar Lunds universitet som nummer 20 i världen inom geografi. Det innebär att vi klättrar från fjolårets placering, 21.Lunds universitet som helhet ökar också sin placering och hamnar på plats 60.Rankingen baseras på tre kriterier: akademiskt anseende, anseende s

https://www.nateko.lu.se/sv/artikel/lunds-universitet-rankad-som-nr-20-i-varlden-inom-geografi - 2025-10-07

Kolportalen ger tillgång till forskningsdata

ICOS Kolportal är den centrala dataportalen för ett europeiskt nätverk för övervakning av växthusgaser. Det ger dig tillgång till forskningsdata från ICOS forskare i hela Europa, och erbjuder resurser och stöd för modellering och utveckling av dataprodukter. Hej Alex Vermeulen! Vad är Carbon Portal?– ICOS Kolportal är det centrala datalagret i ICOS. ICOS är jobbar med övervakning av växthusgaser i

https://www.nateko.lu.se/sv/artikel/kolportalen-ger-tillgang-till-forskningsdata - 2025-10-07

Savanner har nyckelroll i globala kolcykeln

Forskningsreslutat från en internationell forskargrupp, med Anders Ahlström (huvudförfattare) och Ben Smith från INES, avslöjar nyheter som förändrar synen på områden som tidigare inte fått så mycket uppmärksamhet i sammanhanget: de halvtorra ekosystemen, som savann och torra buskmarker, har en nyckelroll i kolets kretslopp. Forskarna har publicerat sina resultat i den ansedda vetenskapliga tidskr

https://www.nateko.lu.se/sv/artikel/savanner-har-nyckelroll-i-globala-kolcykeln - 2025-10-07